Prevagen Products

August 2019: The Vanderwerff case was transferred to a court in the Southern District of New York. (Case No. 19-cv-7582, S. D. NY.)

October 2018: The parties agreed to consolidate this case with Spath v. Quincy Bioscience. The lead case will be Vanderwerff. (Case No. 17-cv-784, D. NJ.)

February 2017: A class-action lawsuit was filed against Quincy Bioscience for allegedly falsely representing that Prevagen supplements improve memory and provide cognitive benefits, and that the benefits of Prevagen are clinically proven when such claims are not true and without adequate support to make them. (Vanderwerff et al v. Quincy Bioscience Holding Company, Inc. et al, Case No. 17-cv-784, D. NJ.).

For more information about’s investigation and legal efforts regarding Prevagen, click here.

For more information about Prevagen and’s coverage of the product, click here.

Print Friendly, PDF & Email

Tags: , ,

Leave a Reply

Back to Top ↑
  • Search Class-Action Tracker

  • Recent Class Actions

  • The Class-Action Tracker is intended to notify consumers about false advertising class-action lawsuits filed around the country, but does not necessarily reflect’s opinion with respect to the lawsuits or disposition of the cases

  • Sign Up for E-mail Updates